This website uses technical, customisation and analytical cookies, both first-party and third-party, to anonymously facilitate browsing and analyse statistics on use of the website. Learn more
Search results
-
Riverside: The Acquisition of Euromed : Investment Process of a Private Equity (Portuguese Version, Brazil)
Martínez Abascal, Eduardo; Sagarra, MartíCase F-962-PBFinanceIn December 2015, Riverside PE (private equity) had to present a blind offer for the acquisition of Euromed, together with the financing of the operation. Euromed produces active ingredients for medical use. Euromed enjoys a profitable niche (good margins), with few competitors, high barriers and promising growth opportunities. It has sales of around 43 million euros, with 300 clients in 35 countries. This case is an updated version of the case ...Starting at €8.20
-
Indexa Capital: Getting Ready for a New Round of Capitalization
Suárez, José Luis; Mariola SorianoCase F-963-EFinance, Information TechnologiesIndexa Capital is Spain's first first robo-advisor. Its founders have experience in entrepreneurship, new technologies and investment management. Indexa specializes in passive investment, following the model established by other companies in the United States and Europe. The company has undergone two rounds of capitalization and is negotiating an agreement for the deferred entry of a new investor, via a loan convertible into shares.Starting at €8.20
-
Riverside: The Acquisition of Euromed : Investment Process of a Private Equity (Portuguese version, Portugal)
Martínez Abascal, Eduardo; Sagarra, MartíCase F-962-PPFinanceIn December 2015, Riverside PE (private equity) had to present a blind offer for the acquisition of Euromed, together with the financing of the operation. Euromed produces active ingredients for medical use. Euromed enjoys a profitable niche (good margins), with few competitors, high barriers and promising growth opportunities. It has sales of around 43 million euros, with 300 clients in 35 countries.Starting at €8.20
-
Riverside: la compra de Euromed: Proceso inversor de una private equity
Martínez Abascal, Eduardo; Sagarra, MartíCase F-962FinanceEn diciembre de 2015 Riverside PE (private equity), tiene que presentar una oferta ciega para la adquisición de Euromed, junto con la financiación de la operación. Euromed produce ingredientes activos para uso médico. Euromed disfruta de un buen nicho rentable (buenos márgenes), con pocos competidores, altas barreras y prometedoras oportunidades de crecimiento. Ventas alrededor de 43 millones de euros, con 300 clientes en 35 países.Starting at €8.20
-
Indexa Capital: preparando una nueva ronda de capitalización
Suárez, José Luis; Mariola SorianoCase F-963Finance, Information TechnologiesIndexa Capital es el primer robo-advisor establecido en España. Sus fundadores tienen experiencia tanto en el emprendimiento como en nuevas tecnologías y gestión de inversiones. Indexa se especializa en inversión pasiva, y sigue el modelo de otras empresas que operan en Estados Unidos y Europa. Han tenido dos rondas de capitalización y negocian un acuerdo para la entrada diferida de un nuevo inversor en su capital. El instrumento elegido es un pr...Starting at €8.20
-
Riverside: The Acquisition of Euromed : Investment Process of a Private Equity
Martínez Abascal, Eduardo; Sagarra, MartíCase F-962-EFinanceIn December 2015, Riverside PE (private equity) had to present a blind offer for the acquisition of Euromed, together with the financing of the operation. Euromed produces active ingredients for medical use. Euromed enjoys a profitable niche (good margins), with few competitors, high barriers and promising growth opportunities. It has sales of around 43 million euros, with 300 clients in 35 countries.Starting at €8.20